Ajax Health

Developer of medical technology software platform designed to provide ways of designing and marketing medical devices. The company's platform embeds strategy and market insights into a collaboration that can be used across various functions, enabling medical companies to build closer relationships with the doctors they serve.

XII Medical is a medical device developer company. It develops a minimally invasive outpatient technology for the treatment of obstructive sleep apnea.

Third Harmonic Bio is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for severe allergies and inflammation. The company is focused on creating first-in-class oral small-molecule inhibitors targeting the KIT receptor, which plays a crucial role in the survival and function of mast cells—key immune cells involved in allergic responses. Its lead product candidate, THB001, is designed to provide selective inhibition of KIT, while another candidate, THB335, aims to address multiple mast cell-driven inflammatory diseases affecting the skin, respiratory system, and gastrointestinal tract. Through its research and development efforts, Third Harmonic Bio seeks to advance the management of inflammatory diseases, enhancing patient outcomes and quality of life.

Developer of medical technology software platform designed to provide ways of designing and marketing medical devices. The company's platform embeds strategy and market insights into a collaboration that can be used across various functions, enabling medical companies to build closer relationships with the doctors they serve.

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions. The company was founded in 2021 and is headquartered in Stamford, CT.

Atriomx develops a solution that delivers deep electrophysiology insights via non-invasive clinical hardware. Atriomx is leveraging advanced data science to transform the way cardiac arrhythmias are understood and improve the way patients are treated - before they undergo costly and invasive treatments. Atriomx’s proprietary algorithms provide unparalleled insight into a patient’s disease state, giving doctors and patients the information they need in order to decide with confidence which treatment is right for each individual patient.

Protaryx Medical Inc. is a medical device company focused on developing advanced transseptal access devices for minimally invasive cardiac procedures. Founded in 2019 and headquartered in Baltimore, Maryland, with engineering operations in Minneapolis, Minnesota, the company aims to enhance access to the left atrium during transcatheter interventions. Its innovative device facilitates precise and rapid septal crossing, providing surgeons with reliable access for catheter-based therapies. By prioritizing meaningful improvements, Protaryx Medical seeks to benefit both healthcare professionals and patients in the realm of cardiac care.

Cortica Inc. is a healthcare company focused on providing neurological therapies for children with autism and other neurodevelopmental challenges. Established in 2014 and based in San Diego, California, Cortica offers personalized treatment programs that are tailored to each child's neurobiology and developmental profile. The company employs a multidisciplinary approach, utilizing insights from emerging neuroscience to deliver comprehensive care through in-home, in-clinic, and telehealth services. Its offerings include evidence-based therapies such as applied behavior analysis (ABA), speech therapy, and occupational therapy, all aimed at fostering independent living, educational opportunities, and social relationships for children with developmental differences. Cortica operates multiple centers in California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village.

Verix Health is developing a suite of actively steerable surgical devices enabling minimally invasive diagnosis and treatment of lesions in difficult-to-access anatomies. The company was founded by Professor Mark Yim, PhD and PCI Ventures at the University of Pennsylvania and incubated at the Pennovation Center in Philadelphia.

EPMap-System GmbH & Co. KG is a German company specializing in the development and manufacture of devices for electrophysiology procedures, particularly focused on heart diagnostics. With over 20 years of experience in the field, the company offers advanced technologies including a 3D mapping and navigation system that integrates electrical signal recording and pacing capabilities, a radiofrequency ablation generator, and an irrigation pump. Their flagship product, EPPerfect, provides a comprehensive solution for recording, stimulation, navigation, and ablation of cardiac conditions, and can be integrated with other systems to enhance functionality. Headquartered in Herdecke, North Rhine-Westphalia, EPMap-System aims to enable hospitals to deliver high-quality care through innovative electrophysiology tools.

Ablacon Inc. is a company based in Wheat Ridge, Colorado, that specializes in developing machine intelligence systems aimed at understanding and treating atrial fibrillation (AF). Founded in 2015, Ablacon's technology provides real-time visualization of electrographic flow within the cardiac chambers, enabling the localization and characterization of AFib sources. This advanced system allows healthcare professionals to guide targeted therapies with greater speed, precision, and reliability, thereby improving patient outcomes in the management of atrial fibrillation.

EPIX Therapeutics develops and manufactures products for use in electrophysiology based on microwave radiometry technology. Its products provide real-time feedback of energy delivered by catheters during cardiac ablation procedures. The company has a strategic relationship with Hansen Medical Inc. Advanced Cardiac Therapeutics, Inc. (ACT), a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation (AFIB), today announced it has changed its name to EPIX Therapeutics, Inc.